Posted on January 20th, 2010 by Kelley Luckstein
It was a bit awkward, to put it mildly. Just as top officials with the Minnesota Partnership for Biotechnology and Medical Genomics announced a major initiative to combat diabetes, something that will require lots of money, a few lawmakers promptly chided the University of Minnesota and Mayo Clinic for cutting money the state had given the partnership…
The state provided the Partnership with millions of dollars, including support for a $25 million, three-story genomics research facility at a Mayo building in Rochester. For that kind of money, politicians expect to see immediate results. Yet the Partnership’s research projects-treatments for heart disease, pancreatic cancer, transplant rejection- take considerable time.
“The time lines are fairly long,” said Robert Rizza, Mayo’s executive dean of research. “The ultimate return on the Partnership’s investments is still out in the future.”
MedCity News, by Thomas Lee, 1/20/10
You must be logged-in to the site to post a comment.